asis and psoriatic arthritis: an observational study. Br J Dermatol 2017; 176:827–8. 6 Krishnan R, Cella D, Leonardi C et al. Effects of etanercept therapy on fatigue and symptoms of… Click to show full abstract
asis and psoriatic arthritis: an observational study. Br J Dermatol 2017; 176:827–8. 6 Krishnan R, Cella D, Leonardi C et al. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 2007; 157:1275–7. 7 Papp K, Crowley J, Ortonne JP et al. Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy. Br J Dermatol 2011; 164:434–41. 8 Eder L, Polachek A, Rosen CF et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol 2017; 69:622–9.
               
Click one of the above tabs to view related content.